Sanjay Gandhi to Tamoxifen
This is a "connection" page, showing publications Sanjay Gandhi has written about Tamoxifen.
Connection Strength
0.070
-
Locker GY, Mansel R, Cella D, Dobrez D, Sorensen S, Gandhi SK. Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial. Breast Cancer Res Treat. 2007 Dec; 106(2):229-38.
Score: 0.070